Fact CheckerSign in

NCT06935292Not yet recruitingPhase 2/3

Oral Melatonin VS Nebulized Dexmedetomidine Premedication on Attenuation of Hemodynamic Response to Direct Laryngoscopy and Tracheal Intubation in Hypertensive Patients

Comparative Study Between Oral Melatonin and Nebulized Dexmedetomidine Premedication on Attenuation of Hemodynamic Response to Direct Laryngoscopy and Tracheal Intubation in Hypertensive Patients: A Prospective Randomized Trial

Source: ClinicalTrials.gov · Last updated 20 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The aim of this study is to compare the efficacy of oral melatonin versus nebulized dexmedetomidine in attenuating the hemodynamic response to direct laryngoscopy and endotracheal intubation in controlled hypertensive patients prepared for general anesthesia

Status (registry)
Not yet recruiting
Phase (registry)
Phase 2/3
Study type
Interventional
Enrollment
70 (estimated)
First submitted
11 Apr 2025
Start date
Apr 2025
Primary completion date
Apr 2026
Lead sponsor
Tanta University
NCT number
NCT06935292

What you commit to

  • Study type: Interventional · Phase 2/3
  • Planned participants: 70
  • From Apr 2025 to the primary completion date, Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients on beta blocker, oral hypoglycemics, anti-depressants, anti-convulsants, anti- psychotics and thyroid medications.

Other illness

  • History of allergy to the drugs of the study.
  • Patients with Heart rate\<50 or Heart block.
  • End stage renal and hepatic disease.

Other

  • Patient refusal to participate in the study.
  • Patient with expected difficult intubation.
  • Body Mass Index (BMI) \> 30 kg/m2.
  • Pregnant or lactating females.

Who the study is looking for

  • Age (40-60) years of both genders.
  • Controlled hypertensive patients.
  • Categorized as ASA physical status II.
  • Planning to do an elective surgery under General Anesthesia.

Age in the registry: 40 years to 60 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Tanta University Hospital
Coordinator of this site? Confirm its status
TantaEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.